MYO1E
protein-codingmyosin IE, the group of Myosin heavy chains, class I|MicroRNA protein coding host genes
Gene summary
This gene encodes a member of the nonmuscle class I myosins which are a subgroup of the unconventional myosin protein family. The unconventional myosin proteins function as actin-based molecular motors. Class I myosins are characterized by a head (motor) domain, a regulatory domain and a either a short or long tail domain. Among the class I myosins, this protein is distinguished by a long tail domain that is involved in crosslinking actin filaments. This protein localizes to the cytoplasm and may be involved in intracellular movement and membrane trafficking. Mutations in this gene are the cause of focal segmental glomerulosclerosis-6. This gene has been referred to as myosin IC in the literature but is distinct from the myosin IC gene located on chromosome 17. [provided by RefSeq, Jan 2012]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~240.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0013589
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0019006
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0013589
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0013589
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Renal
Intervention: Renal
Rationale: The condition can involve early-onset renal disease, and awareness may allow prompt diagnosis and management (eg, glucocorticoid and cyclosporine use has been descvribed as beneficial); Renal transplant has been described
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to MYO1E variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_004998.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 16 | 87 | 1 | 104 | ||
| missense | 1 | 4 | 298 | 15 | 1 | 319 |
| nonsense | 9 | 8 | 1 | 18 | ||
| start loss | 0 | |||||
| frameshift | 1 | 6 | 7 | |||
| splice donor/acceptor (+/-2bp) | 1 | 1 | 3 | 5 | ||
| Total | 12 | 19 | 318 | 102 | 2 | 453 |
Highest pathogenic variant AF is 0.000006201812
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_004989.2 | 28 | MANE Select | |
| Ensembl | ENSP00000288235.4 | 28 | MANE Select | |
| Ensembl | ENSP00000453811.1 | 5 | Standard | |
| Ensembl | ENSP00000453232.1 | 6 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- miR-targeted genes in epithelium - TarBase
- miR-targeted genes in lymphocytes - TarBase
- miR-targeted genes in muscle cell - TarBase
- Primary Focal Segmental Glomerulosclerosis FSGS
Biological Process
- vasculogenesis
- in utero embryonic development
- glomerular filtration
- nitrogen compound metabolic process
- endocytosis
Molecular Function
- microfilament motor activity
- motor activity
- protein binding
- calmodulin binding
- ATP binding
Cellular Component
- cytoplasm
- cytoskeleton
- brush border
- cell-cell junction
- adherens junction
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000288235
- Coding exons
- 28
- Length
- 237987
- Individuals with no LoFs
- 125716
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 32
- Defined
- 125748
- p
- 0.000127
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.169 | 600 | 612 | 0.981 | 0.0000364 | 7363 |
| Missense (PolyPhen) | 261 | 298.5 | 0.87436 | 3582 | ||
| Synonymous | -1.61 | 265 | 234 | 1.13 | 0.0000152 | 1995 |
| Loss of Function | 5.32 | 21 | 68.5 | 0.307 | 0.00000386 | 772 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00018 | 0.00018 | rare |
| Latino/Admixed American | 0.00023 | 0.00023 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.00011 | 0.00011 | rare |
| South Asian | 0.00013 | 0.00013 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Myosins are actin-based motor molecules with ATPase activity. Unconventional myosins serve in intracellular movements. Their highly divergent tails bind to membranous compartments, which are then moved relative to actin filaments. Binds to membranes containing anionic phospholipids via its tail domain. Required for normal morphology of the glomerular basement membrane, normal development of foot processes by kidney podocytes and normal kidney function. In dendritic cells, may control the movement of class II-containing cytoplasmic vesicles along the actin cytoskeleton by connecting them with the actin network via ARL14EP and ARL14. {ECO:0000269|PubMed:11940582, ECO:0000269|PubMed:17257598, ECO:0000269|PubMed:20860408}.;
Recessive Scores
- pRec
- 0.132
Intolerance Scores
- LoFtool
- 0.0965
- RVIS EVS
- -1.14
- RVIS percentile EVS
- 6.38
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.846
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |